AurorA-TT Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 5
  • Investments
  • 1
  • Portfolio
  • 1

AurorA-TT General Information


Founded in 2017, AurorA-TT is a venture capital and technology transfer intermediation firm based in Milan, Italy. The firm focuses on early-stage biotech and pharma companies based in Italy. The firm prefers to invest in pre-seed and seed projects to bridge the gap between basic research and industrial drug development with industrial discipline. The firm's portfolio is focused on the oncology, immunology, rare diseases, infectious diseases, cardiovascular diseases and CNS diseases.

Contact Information

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Primary Office
  • Via dell'Annunciata, 31
  • 20121 Milan
  • Italy
+39 02 0000 0000

AurorA-TT Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
00000000 16-Dec-2020 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 1 00000 00000 00
To view AurorA-TT’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AurorA-TT Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

AurorA-TT Team (5)

Name Title Deals Funds Boards Office
Edoardo Negroni Co-Founder & Managing Partner 0 Milan, Italy
Gabriele Campi Co-Founder & Managing Partner 0 Milan, Italy
G. Paolo Rizzardi MD Co-Founder & Managing Partner Milan, Italy
Guido Guidi MD Co-Founder, Managing Partner and Chairman 0 0 Milan, Italy
Pierluigi Paracchi Co-Founder and Venture Consultant 0 Luxembourg, Luxembourg
To view AurorA-TT’s complete team members history, request access »